Issue 3-21, 2022

Original article

https://doi.org/10.38025/2078-1962-2022-21-3-24-29

Use of Probiotics in Treatment and Rehabilitation of Patients after a New Coronavirus Infection

View article (Download PDF file)



Download XML file

1 ORCIDPavel A. Markov, 1 ORCIDIrina S. Kudryashova, 1 ORCIDPetr S. Eremin, 1 ORCIDElena Yu. Kostromina, 1 ORCIDIlmira R. Gilmutdinova, 1 ORCIDAndrey P. Rachin

1 National Medical Research Center of Rehabilitation and Balneology, Moscow, Russian Federation


ABSTRACT

As of January 2022, 343 million cases of SARS-CoV-2 were reported globally. COVID-19 is a multi-faceted, multi-systemic illness in whichall age groups are susceptible. A number of research findings have shown that COVID-19 is associated with dysbiosis, leading to thedevelopment of local and systemic pathologies. It was found that the use of probiotics in the complex therapy of patients with COVID-19 reduces the severity of the disease and the development of complications. According to the researchers, several mechanisms couldexplain the therapeutic effect of probiotics, including the ability to suppress pro-inflammatory cytokine formation and modulate thefunctional activity of the immune system. In Russia, probiotics in the treatment of COVID-19 patients are only used to correct diarrhea,while literature suggests that probiotics have much greater therapeutic potential. Introducing oral bacterial therapy into the treatmentand rehabilitation of COVID-19 patients requires further clinical trials.


KEYWORDS: COVID-19, probiotics, bifidobacteria, lactobacilli, intestinal microflora, inflammation

FOR CITATION: Markov P.A., Kudryashova I.S., Eremin P.S., Kostromina E.Yu., Gilmutdinova I.R., Rachin A.P. Use of Probiotics in Treatment and Rehabilitation of Patients after a New Coronavirus Infection. Bulletin of Rehabilitation Medicine. 2022; 21 3): 24-29. https://doi.org/10.38025/2078-1962-2022-21-3-24-29


References:

  1. Coronavirus. Coronavirus statistics in Russia and the world in real time. Available at: https://coronavirus-monitor.info/ (accessed 25.08.2021) (In Russ.).
  2. Liu H., Chen S., Liu M., Nie H., Lu H. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis. Aging and Disease. 2020; 11(3): 668-678. https://doi.org/10.14336/AD.2020.0502
  3. Eastin C., Eastin T. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumo- nia in Wuhan, China. The Journal of Emergency Medicine. 2020; 58(4): 713-714. https://doi.org/10.1016/J.JEMERMED.2020.04.007
  4. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497- 506. https://doi.org/10.1016/S0140-6736(20)30183-5
  5. Qiurong R., Kun Y., Wenxia W., Lingyu J., Jianxin S. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020; 46(5): 846-848. https://doi.org/10.1007/S00134-020-05991-X
  6. Hu J., Zhang L., Lin W., Tang W., Chan F.K.L., Ng S.C. Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic. Trends in Food Science & Technology. 2021; (108): 187-196. https://doi.org/10.1016/J.TIFS.2020.12.009
  7. Aktas B. Gut Microbiota Dysbiosis and COVID-19: Possible Links. Comprehensive Gut Microbiota. 2021; 9(1): 1-9. https://doi.org/10.1016/B978-0-12-819265-8.00072-3
  8. Meng G., Wanyin T., Richard A.F., Shu Z. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nature Reviews Gastroenterology & Hepatology. 2021; 18(4): 269-283. https://doi.org/10.1038/S41575-021-00416-6
  9. Lin L., Jiang X., Zhang Z. et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020; 69(6): 997-1001. https://doi.org/10.1136/GUTJNL-2020-321013
  10. Song Y., Liu P., Shi X.L. et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020; 69(6): 1143-1144. https://doi.org/10.1136/GUTJNL-2020-320891
  11. Jin X., Lian J.S., Hu J.H. et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69(6): 1002-1009. https://doi.org/10.1136/GUTJNL-2020-320926
  12. Pan L., Mu M., Yang P. et al. Clinical Characteristics of COVID-19 Patients with Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. The American Journal of Gastroenterology. 2020; 115(5): 766-773. https://doi.org/10.14309/AJG.0000000000000620
  13. Wan Y., Li J., Shen L. et al. Enteric involvement in hospitalised patients with COVID-19 outside Wuhan. The Lancet Gastroenterology & Hepatology. 2020; 5(6): 534-535. https://doi.org/10.1016/S2468-1253(20)30118-7
  14. Ichinohe T., Pang I., Kumamoto Y. et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(13): 5354-5359. https://doi.org/10.1073/PNAS.1019378108
  15. Shenderov B.A. Metabiotics: novel idea or natural development of probiotic conception. Microbial Ecology in Health & Disease. 2013; 24(0): 44-49. https://doi.org/10.3402/MEHD.V24I0.20399
  16. Hooper L., Gordon J. Commensal host-bacterial relationships in the gut. Science. 2001; 292(5519): 1115-1118. https://doi.org/10.1126/SCIENCE.1058709
  17. Chervonsky A. Innate receptors and microbes in induction of autoimmunity. Current Opinion in Immunology. 2009; 21(6): 641-647. https://doi.org/10.1016/J.COI.2009.08.003
  18. King S., Glanville J., Sanders M., Fitzgerald A., Varley D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. The British Journal of Nutrition. 2014; 112(1): 41-54. https://doi.org/10.1017/S0007114514000075
  19. Qiukui H., Bi R.D., Taixiang W. Probiotics for preventing acute upper respiratory tract infections. The Cochrane Database of Systematic Reviews. 2015; 2015(2): 3 p. https://doi.org/10.1002/14651858.CD006895.PUB3
  20. Chong H. X., Asmaa N., Yusoff A. et al. Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study. Journal of Dairy Science. 2019; 102(6): 4783-4797. https://doi.org/10.3168/JDS.2018-16103
  21. Mechanick J. I., Carbone S., Dickerson R. N. et al. Clinical Nutrition Research and the COVID-19 Pandemic: A Scoping Review of the ASPEN COVID-19 Task Force on Nutrition Research. Journal of Parenteral and Enteral Nutrition. 2021; 45(1): 13-31. https://doi.org/10.1002/JPEN.2036
  22. Infusino F., Marazzato M., Mancone M. et al. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review. Nutri- ents. 2020; 12(6): 1-21. https://doi.org/10.3390/NU12061718
  23. Sanders M.E., Merenstein D.J., Ouwehand A.C. et al. Probiotic use in at-risk populations. Journal of the American Pharmacists Association. 2016; 56(6): 680-686. https://doi.org/10.1016/J.JAPH.2016.07.001
  24. d’Ettorre G., Ceccarelli G., Marazzato M. et al. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Comple- mentary Therapeutic Strategy to Avoid the Progression of COVID-19. Frontiers in Medicine. 2020; (1): 389 p. https://doi.org/10.3389/fmed.2020.00389
  25. Dermyshi E., Wang Y., Yan C. et al. The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants. Neonatology. 2017; 112(1): 9-23. https://doi.org/10.1159/000454668
  26. Hill C., Guarner F., Reid G. et al. Expert consensus document: The international scientific association for probiotics and prebiotics consen- sus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology. 2014; 11(8): 506-514. https://doi.org/10.1038/NRGASTRO.2014.66
  27. Gao Q.Y., Chen Y.X., Fang J.Y. 2019 Novel coronavirus infection and gastrointestinal tract. Journal of Digestive Diseases. 2020; 21(3): 125-126. https://doi.org/10.1111/1751-2980.12851



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©


This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.